Vitamin D3 affects differentiation, maturation, and function of human monocyte-derived dendritic cells

Journal of Immunology

Volumn 164, Issue 9, 2000, Pages 4443-4451

  Piemonti, Lorenzo ^a,b   Monti, Paolo ^b   Sironi, Marina ^c   Fraticelli, Paolo ^c   Leone, Biagio Eugenio ^a,b   Cin, Elena Dal ^a   Allavena, Paola ^c   Di Carlo, Valerio ^a,b  

^a SAN RAFFAELE HOSPITAL   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

^c MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

B7 ANTIGEN; CALCITRIOL; CD1 ANTIGEN; CD14 ANTIGEN; CD32 ANTIGEN; CD40 ANTIGEN; CD83 ANTIGEN; CD86 ANTIGEN; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 4; LIPOPOLYSACCHARIDE; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MANNOSE RECEPTOR; ANTIGEN; DIHYDROXY VITAMIN D3; DIHYDROXY-VITAMIN D3; DRUG DERIVATIVE; IMMUNOLOGICAL ADJUVANT; IMMUNOSUPPRESSIVE AGENT; INTERLEUKIN 12; VITAMIN D;

ANTIGEN PRESENTING CELL; ARTICLE; CELL DIFFERENTIATION; CELL FUNCTION; CELL MATURATION; CELL STIMULATION; CELL STRUCTURE; CONTROLLED STUDY; DENDRITIC CELL; DRUG EFFECT; ENDOCYTOSIS; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNE SYSTEM; IMMUNOMODULATION; PHENOTYPE; PRIORITY JOURNAL; BIOSYNTHESIS; CELL CULTURE; CYTOLOGY; IMMUNOLOGICAL TOLERANCE; IMMUNOLOGY; METABOLISM; MONOCYTE; T LYMPHOCYTE;

ADJUVANTS, IMMUNOLOGIC; ANTIGENS; CELL DIFFERENTIATION; CELLS, CULTURED; DENDRITIC CELLS; HUMANS; IMMUNE TOLERANCE; IMMUNOSUPPRESSIVE AGENTS; INTERLEUKIN-12; MONOCYTES; T-LYMPHOCYTES; VITAMIN D;

EID: 0034178251     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.164.9.4443     Document Type: Article

References (71)

1. 3. Kidney Int. 38(Suppl. 29):S-9.
2. 3 and the immune system. Mol. Cell. Endocrinol. 43: 113.
3. 3. J. Steroid Biochem. Mol. Biol. 53:599.
4. Hewison, M. 1992. Vitamin D and the immune system. J. Endocrinol. 132:173.
5. 3 on the induction of experimental autoimmune thyroiditis. Clin. Immunol. Immunopathol. 54:53.
6. 3 prevents the in vivo induction of murine experimental autoimmune encephalomyelitis. J. Clin. Invest. 87:1103.
7. 3 reversibly blocks the progression of relapsing encephalomyelitis, a model of multiple sclerosis. Proc. Natl. Acad. Sci. USA 93:7861.
8. Hayes, C. E., M. T. Cantoma, and H. F. DeLuca. 1997. Vitamin D and multiple sclerosis. Proc. Soc. Exp. Biol. Med 216:21.
9. 3. J. Neuroimmunol. 61: 151.
10. Lillevang, S. T., J. Rosenkvist, C. B. Andersen, S. Larsen, E. Kemp, and T. Kristensen. 1992. Single and combined effects of the vitamin D analogue KH1060 and cyclosporine A on mercuric-chloride-induced autoimmune disease in the BN rat. Clin. Exp. Immunol. 88:301.
11. 3. Clin. Exp. Immunol. 94:412.
12. 3 on experimental rat nephrotoxic serum nephritis. Nippon Jinzo Gakkai Shi. 32:147.
13. 3 against the development of diabetes induced by multiple low dose streptozotocin injection in CD-1 mice. Metabolism 41:631.
14. 3 prevents insulitis in NOD mice. Diabetes 41: 1491.
15. 3. Diabetologia 37:552.
16. 3 in combination with cyclosporine A. Transplant. Proc. 28:3095.
17. 3 prolongs skin graft survival in mice. In Vitamin D: Molecular, Cellular and Clinical Endocrinology. A. W. Norman, K. Schaefer, H.-G. Grigoleit, and D. von Herrath, eds. Walter de Gruytcr, Berlin, p. 346.
18. 3 prolong rat cardiac allograft survival. In Vitamin D: Molecular, Cellular and Clinical Endocrinology. A. W. Norman, K. Schaefer, H.-G. Grigoleit, and D. von Herrath, eds. Walter de Gruyter, Berlin, p. 334.
19. 3 analogue 1,25-dihydroxy-delta 16-cholecalciferol. Transplantation 54:762.
20. Veyron, P., R. Pamphile, L. Binderup, and J.-L. Touraine. 1993. Two novel vitamin D analogues, KH1060 and CB 966, prolong skin allograft survival in mice. Transplant. Immunol. 1:72.
21. 3 receptors in human leukocytes. Science 221:1181.
22. 3 in human peripheral blood mononuclear cells: presence in monocytes and induction in T lymphocytes following activation. J Clin. Endocrinol Metab. 68:774.
23. 3: a novel immunoregulalory hormone. Science 224:1438.
24. 3. J. Clin. Endocrinol. Metab. 69:127.
25. 3 suppresses proliferation and immunoglobulin production by normal human peripheral blood mononuclear cells. J. Clin. Invest. 74:657.
26. 3. J. Clin. Invest. 79:1659.
27. 3 and its fluorinated analogues. Cancer Res. 44:5624.
28. 3. Proc. Natl. Acad. Sci. USA 78:4990.
29. Tanaka, H., E. Abe, C. Miyaura, T. Kuribayashi, K. Konno, Y. Nishii, and T. Suda. 1986. 1,25-Dihydroxycholecalciferol and a human myeloid leukemia cell line (HL-60). Biochem. J. 204:713.
30. 3. Blood 76:2457.
31. Walters, M. R. 1992. Newly identified actions of the vitamin D endocrine system. Endocr. Rev. 13:719.
32. 3 exerts opposing effects to IL-4 on MHC class II antigen expression, accessory activity, and phagocytosis of human monocytes. Scand. J. Immunol. 38:535.
33. 3: stimulation of defective migration of AIDS patients. J. Immunol. 145:2459.
34. Romani, N., S. Gruner, D. Brang, E. Kampgen, A. Lenz, B. Trockenbacher, G. Konwalinka, P. O. Fritsch, R. M. Steinman, and G. Schuler. 1994. Proliferating dendritic cell progenitors in human blood. J. Exp. Med. 180:83.
35. Sallusto, F., and A. Lanzavecchia. 1994. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor α. J. Exp. Med. 179:1109.
36. Chapuis, F., M. Rosenzwajg, M. Yagello, M. Ekman, P. Biberfeld, and J. C. Gluckman. 1997. Differentiation of human dendritic cells from monocytes in vitro. Eur. J. Immunol. 27:431.
37. Piemonti, L., S. Bernasconi, W. Luini, Z. Trobonjaca, A. Minty, P. Allavena, and A. Mantovani. 1995. IL-13 supports differentiation of dendritic cells from circulating precursors in concert with GM-CSF. Eur. Cytokine Network 6:245.
38. Sallusto, F., M. Cella, C. Danieli, and A. Lanzavecchia. 1995. Dendritic cells use macropinocytosis and the mannose receptor to concentrate macromolecules in the major histocompatibility complex class II compartment: downregulation by cytokines and bacterial products. J. Exp. Mep. 182:389.
39. Grabbe, S., S. Beissert, T. Schwarz, and R. D. Granstein. 1994. Dendritic cells as initiators of immune responses: a possible strategy for tumor immunotherapy? Immunol. Today 24:2691.
40. Sallusto, F., and A. Lanzavecchia. 1999. Mobilizing dendritic cells for tolerance, priming, and chronic inflammation. J. Exp. Med. 189:611.
41. Schuler, G., and R. M. Steinman. 1997. Dendritic cells as adjuvants for immune-mediated resistance to tumors. J. Exp. Med. 186:1183.
42. Morel, A. S., S. Quarantino, D. C. Douek, and M. Londei. 1997. Split activity of interleukin-10 on antigen capture and antigen presentation by human dendritic ceils: definition of a maturative step. Eur. J. Immunol 27:26.
43. Buelens, C., V. Verhasselt, D. De Groote, K. Thielemans, M. Goldman, and F. Willems. 1997. Interleukin-10 prevents the generation of dendritic cells from human peripheral blood mononuclear cells cultured with interleukin-4 and granulocyte/macrophage-colony-stimulating factor. Eur. J. Immunol. 27:756.
44. Uccini, S., M. C. Sirianni, L.Vincenzi, S. Topino, A. Stopacciaro, I. Lesnoni, C. La Parola, C. Masini, D. Cerimele, M. Cella, et al. 1997. Kaposi's sarcoma cells express the macrophage-associated antigen mannose receptor and develop in peripheral blood cultures of Kaposi's sarcoma patients. Am. J. Pathol. 150:929.
45. Biondi, A., T. H. Rossing, J. Bennett, and R. F. Todd. 1984. Surface membrane heterogeneity among human mononuclear phagocytes. J. Immunol. 132:1237.
46. 3 as a natural regulator of human immune function. J. Invest Dermatol. 1:68.
47. Banchereau, J., and R. M. Steinman. 1998. Dendritic cells and the control of immunity. Nature 392:245.
48. Steinman, R. M. 1991. The dendritic cell system and its role in immunogenicity. Annu. Rev. Immunol. 9:271.
49. Hart, D. N. J. 1997. Dendritic cells: unique leukocyte populations which control the primary immune response. Blood 90:3245.
50. Allavena, P., L. Piemonti, D. Longoni, S. Bernasconi, A. Stopacciaro, L. Ruco, and A. Mantovani. 1998. Interleukin-10 prevents the differentiation of monocytes to dendritic cells but promotes their maturation to macrophages. Eur. J. Immunol. 28:359.
51. Piemonti, L., P. Monti, P. Allavena, M. Sironi, L. Soldini, B. E. Leone, C. Socci, and V. Di Carlo. 1999. Glucocorticoids affect human dendritic cell differentiation and maturation. J. Immunol. 162:6473.
52. 3 differentiates normal neutrophilic promyelocytes to monocytes/macrophages in vitro. Blood 87:2693.
53. Takahashi, T., K. Nakamura, and S. Iho. 1997. Differentiation of myeloid cells and 1,25-dihydroxyvitamin D3. Leukemia Lymphoma 27:25.
54. Suda, T., T. Shinki, and N. Takahashi. 1990. The role of vitamin D in bone and intestinal cell differentiation. Annu. Rev. Nutr. 10:195.
55. Fujikawa, Y., J. M. Quinn, A. Sabokbar, J. O. McGee, and N. A. Athanasou. 1996. The human osteoclast precursor circulates in the monocytes fraction. Endocrinology 137:4058.
56. Palucka, K. A., N. Taquet, F. Sanchez-Chapuis, and J. C. Gluckman. 1998. Dendritic cells as the terminal stage of monocyte differentiation. J. Immunol. 160: 4587.
57. Cella, M., D. Scheidegger, K. Palmer-Lehmann, P. Lane, A. Lanzavecchia, and G. Albert. 1996. Legation of CD40 on dendritic cells triggers production of high levels of interleukin-12 and enhances T cell stimulatory capacity: T-T help via APC activation. J. Exp. Med. 184:747.
58. + dendritic cells. Proc. Natl. Acad. Sci. USA 93:2588.
59. + T cells. J. Immunol. 154:5071.
60. Heufler, C., K Koch, U. Stanzl, G. Topar, M. Wysocka, G. Trinchieri, A. Enk, R. M. Steinman, and N. Romani. 1996. Interleukin-12 is produced by dendritic cells and mediates T helper 1 development as well as interferon γ production by T helper 1 cells. Eur. J. Immunol. 26:649.
61. 3. J. Clin. Invest. 101:252.
62. Romani, N., D. Reider, M. Heuer, S. Ebner, E. Kampgen, B. Eibl, D. Niederwieser, and G. Schuler. 1996. Generation of mature dendritic cells from human blood an improved method with special regard to clinical applicability. J. Immunol. Methods 196:137.
63. Steinbrink, K., M. Wolfl, H. Jonuleit, J. Knop, and Enk, A. H. 1997. Induction of tolerance by IL-10 treated dendritic cells. J. Immunol. 159:4772.
64. Bouillon, R., and H van Baelen. 1981. Transport of vitamin D: significance of free and total concentration of the vitamin D metabolites. Calcif. Tissue Int. 33:451.
65. Ross, T. K., H. M. Darwish, and H. F. DeLuca. 1994. Molecular biology of vitamin D action. Vitam. Horm. 49:281.
66. Yang, S., C. Smith, J. M. Prahl, and H. F. DeLuca. 1993. Vitamin D deficiency suppresses cell-mediated immunity in vivo. Arch. Biochem. Biophys. 303:98.
67. 2 suppresses immunoglobulin production and thymic lymphocyte proliferation in vivo. Biochim. Biophys. Acta 1158:279.
68. Silva, M. E., M. E. C. Silva, J. R. Nicoli, E. A. Bambirra, and E. C. Vieira. 1993. Vitamin D overload and experimental Trypanosoma cruzi infection: parasitological and histopathological aspects. Comp. Biochem. Physiol. 104:175.
69. + cells in skin of patients with polymorphous light eruption. J. Invest. Dermatol. 113:4.
70. Dittmar, H. C., J. M. Weiss, C. C. Termeer, R. W. Denfeld, M. B. Wanner, L. Skov, J. N. Barker, E. Schopf, O. Baadsgaard, and J. C. Simon. 1999. In vitro UVA-1 and UVB irradiation differentially perturbs the antigen-presenting function of human epidermal Langerhans cells. J. Invest. Dermatol. 112:322.
71. Boonstra, A., and H. F. Savelkoul. 1997. The role of cytokines in ultraviolet-B induced imtnunosuppression, Eur. Cytokine Network 8:117.